Table 4. Secondary outcomes, per protocol population.
| Standard care | Prone | Outcome measure | P value | ||||
|---|---|---|---|---|---|---|---|
| n | Summary Statistic | n | Summary Statistic | 95% CI | P value | ||
| Intubation and MV within 28 days n(%) | 46 | 8 (17%) | 44 | 6 (14%) | RR 0.78 | 0.28, 2.08 | 0.62 |
| 28-day mortality n(%) | 46 | 8 (17%) | 44 | 8 (18%) | RR 1.05 | 0.42, 2.61 | 0.92 |
| In-hospital mortality n(%) | 46 | 11 (24%) | 44 | 10 (23%) | RR 0.95 | 0.44, 2.04 | 0.89 |
| Duration hospital stay (days) (median, IQR) | 46 | 13 (10, 21) | 44 | 11 (9, 16) | Beta -1.73 | -8.36, 4.91 | 0.61 |
| Duration of oxygen therapy
1
(days) (median,
IQR) |
46 | 6 (3,7) | 44 | 5 (3,6) | Beta -1.25 | -3.48, 0.97 | 0.27 |
| Ventilator free days 2 (median, IQR) | 46 | 11 (9,17) | 44 | 9 (8,15) | Beta -2.41 | -5.0, 0.2 | 0.07 |
1. Supplemental oxygen via low flow nasal canulae/mask or HFNC
2. Ventilation free days until hospital discharge